BOT 1.45% 35.0¢ botanix pharmaceuticals ltd

Bot Chart, page-10600

  1. 1,684 Posts.
    lightbulb Created with Sketch. 1087
    It's pretty clear, to the rest of the entire investing world, that the FDA's Complete Response Letter was not a 'rejection' of Sofdra, but rather was "the FDA will approve Sofdra when BOT fix some minor instruction issues and labelling". Everybody knows that!
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
0.005(1.45%)
Mkt cap ! $527.6M
Open High Low Value Volume
34.0¢ 35.0¢ 33.5¢ $1.130M 3.301M

Buyers (Bids)

No. Vol. Price($)
6 214285 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 213917 9
View Market Depth
Last trade - 12.24pm 27/06/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.